) has been revised to $8.92 / share. This is a decrease of 27.08% from the prior estimate of $12.24 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
) has been revised to $7.65 / share. This is a decrease of 14.29% from the prior estimate of $8.92 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...
We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...
We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where Microbot Medical Inc. (NASDAQ:MBOT) stands against ...
Microbot Medical Inc. MBOT recently announced that it has submitted a 510(k) premarket notification to the FDA for its LIBERTY system. The 510(k) submission follows the successful completion of its ...
Microbot Medical Inc. MBOT recently signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The company has received the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results